I think the tech is sexy with good global reach and really just needs to see top line growth. At the 10c equivalent market cap it was a steal! However I would be very surprised if they are able to become cash flow positive within the next 24 months.
The existing product lines would be amazing as a plug in for some big pharma and we just take a royalty on sales rather than appointing small distributors here and there that hasn’t done much in terms of actual top line growth IMO
Ann: Collaboration With Healthcare Group To Develop New Products, page-13
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
0.002(5.00%) |
Mkt cap ! $4.853M | |||
| Open | High | Low | Value | Volume |
| 3.8¢ | 4.5¢ | 3.8¢ | $80.72K | 1.996M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 322736 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 1121312 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| OSX (ASX) Chart |